Skip to main content
VREX logo

VREX · Varex Imaging Corp · Financials

Track VREX — free
$18.49 +0.03 (+0.16%)
Market Cap
$776.75M
Shares
42.10M
Volume · Oct 5 73.97K Avg daily vol (3M) 830.67K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$844.6M +4.1%
FY2025 Revenue FY2015–FY2025
Net Income
-$70.3M -44.1%
FY2025 Net Income FY2015–FY2025
Gross Margin
34.39% +2.7pp
FY2025 Gross Margin FY2015–FY2025
Operating Margin
-3.29% -7.2pp
FY2025 Operating Margin FY2015–FY2025
Diluted EPS
-$1.70 -41.7%
FY2025 Diluted EPS FY2015–FY2025
Operating Cash Flow
$41.7M -11.8%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
$860M – $880M $865M $844.6M $811M $893.4M $859.4M $818.1M $738.3M $780.6M $773.4M $698.1M $620.1M $632.3M
— $568.1M $554.1M $554.1M $603.1M $575.9M $546.6M $548.1M $523.9M $519.5M $444.6M $371.7M $381.7M
— $296.9M $290.5M $256.9M $290.3M $283.5M $271.5M $190.2M $256.7M $253.9M $253.5M $248.4M $250.6M
— — 34.39% 31.68% 32.49% 32.99% 33.19% 25.76% 32.88% 32.83% 36.31% 40.06% 39.63%
— $91.4M $91.1M $87M $84.8M $77M $71.9M $78.9M $78.1M $83M $67.3M $53.5M $50.4M
— $133.3M $133.3M $137.8M $128.4M $118.3M $125.5M $142.2M $128.1M $123.4M $102.5M $85.8M $72.7M
— $4.4M $4M $9.9M $13.7M $14.6M $16.8M $17.2M $15.7M $16.2M $10.5M $5.5M $2.7M
— $224.7M $318.3M $224.8M $213.2M $195.3M $197.4M $223.9M $211M $209.4M $169.8M $139.3M $123.1M
— $72.2M -$27.8M $32.1M $77.1M $88.2M $74.1M -$33.7M $45.7M $44.5M $83.7M $109.1M $127.5M
— — -3.29% 3.96% 8.63% 10.26% 9.06% -4.56% 5.85% 5.75% 11.99% 17.59% 20.16%
— $38.8M $35.5M $30.2M $29.3M $39.8M $42.1M $31.4M $21.1M $21.7M $12.3M $1.9M $1.2M
— $2.9M $8.5M $7.3M $3.7M $400K $100K $100K $100K $200K $200K $300K $500K
— -$44.5M -$31.4M -$27.1M -$45.8M -$43.7M -$45.5M -$38.9M -$24.2M -$18.8M -$8.9M -$4.1M $100K
— — -$2.3M -$1M -$1.4M -$3M -$3.4M -$2.1M -$2.3M $3.9M $1.3M -$1.6M $300K
— $27.7M -$59.2M $5M $31.3M $44.5M $28.6M -$72.6M $21.5M $25.7M $74.8M $105M $127.6M
— $5.2M $10.7M $53.3M -$16.6M $13.7M $10.7M -$15.2M $5.7M -$2.6M $22.8M $36M $46.8M
— $22.1M -$70.3M -$48.8M $47.4M $30.3M $17.4M -$57.9M $15.5M $27.5M $51.6M $68.5M $80M
— — -8.32% -6.02% 5.31% 3.53% 2.13% -7.84% 1.99% 3.56% 7.39% 11.05% 12.65%
— $400K $400K $500K $500K $500K $500K $500K $300K $800K $400K $500K $800K
— — — — — $30.3M $17.4M -$57.9M — — — — —
— $24.6M -$72.6M -$50.5M $46.1M $30.4M $16.6M -$55.4M $8M $32.5M $52.4M $68.6M $79.9M
USD/shares — $0.53 -$1.70 -$1.20 $1.18 $0.76 $0.44 -$1.49 $0.41 $0.73 $1.37 $1.83 $2.14
USD/shares $0.80 – $1.00* $0.52 -$1.70 -$1.20 $1.07 $0.73 $0.43 -$1.49 $0.40 $0.72 $1.36 $1.82 $2.12
shares — — 41.4M 40.8M 40.3M 39.8M 39.3M 38.8M 38.2M 37.9M 37.6M 37.4M 37.4M
shares — — 41.4M 40.8M 50.3M 41.6M 40.3M 38.8M 38.6M 38.4M 38M 37.7M 37.7M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-07-03 USD 400,000 10-Q filed 2026-08-10
Current operating lease liabilities 2026-07-03 USD 4,500,000 10-Q filed 2026-08-10
Long-term debt, including current maturities 2026-07-03 USD 347,100,000 10-Q filed 2026-08-10
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term debt
USD 18,200,000
Noncurrent debt carrying amount
USD 328,900,000
Noncurrent finance lease liabilities 2026-07-03 USD 5,300,000 10-Q filed 2026-08-10
Noncurrent operating lease liabilities 2026-07-03 USD 22,000,000 10-Q filed 2026-08-10
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
1.18×
Peer median 2.53×
EV/EBIT
14.19×
Peer median 23.96×
P/E (TTM)
35.48×
Peer median 22.60×
EV/Adj. EBITDA (FY2025)
8.25×
Peer median 9.94×

Peer medians compare against the 66 similar-size Medical Devices companies (of 150 listed).

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Medical Segment $592,600,000 $581,700,000 $673,300,000 $674,700,000 $643,800,000 $584,500,000 $596,800,000 $602,000,000
Industrial Segment $252,000,000 $229,300,000 $220,100,000 $184,700,000 $174,300,000 $153,800,000 $183,800,000 $171,400,000

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Other Countries $317,900,000 $317,200,000 $314,900,000 — — — — —
United States $254,900,000 $257,700,000 $275,100,000 $263,700,000 $262,300,000 $249,800,000 $275,300,000 $268,800,000
Japan $143,500,000 $118,100,000 $156,600,000 — — — — —
China $128,300,000 $118,000,000 $146,800,000 — — — — —
Americas — — — $273,300,000 $268,500,000 $255,000,000 $282,600,000 —
Asia Pacific — — — $305,300,000 $273,300,000 $251,800,000 $229,000,000 $243,100,000
Latin America — — — — — $5,200,000 $7,300,000 $7,000,000
EMEA — — — $280,800,000 $276,300,000 $231,500,000 $269,000,000 $254,500,000
Key facts CIK 1681622 CUSIP 92214X106 13F (30d) 7 filings 5 filers Visit website Investor relations